======= NAA40 =======
== Gene Information ==
* **Official Symbol**: N/AA40
* **Official Name**: N-alpha-acetyltransferase 40, NatD catalytic subunit
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=79829|79829]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q86UY6|Q86UY6]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=NAA40&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NAA40|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/619999|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: N-alpha-acetyltransferase that specifically mediates the acetylation of the N-terminal residues of histones H4 and H2A (PubMed:21935442, PubMed:25619998). In contrast to other N-alpha- acetyltransferase, has a very specific selectivity for histones H4 and H2A N-terminus and specifically recognizes the 'Ser-Gly-Arg- Gly sequence' (PubMed:21935442, PubMed:25619998). Acts as a negative regulator of apoptosis (PubMed:26666750). May play a role in hepatic lipid metabolism (By similarity). {ECO:0000250|UniProtKB:Q8VE10, ECO:0000269|PubMed:21935442, ECO:0000269|PubMed:25619998, ECO:0000269|PubMed:26666750}.
|Acetyltransf 1|
|H2A histone acetyltransferase activity|
|peptide-serine-N-acetyltransferase activity|
|regulation of chromatin silencing at rDNA|
|H4 histone acetyltransferase activity|
|N-terminal protein amino acid acetylation|
|histone H2A acetylation|
|N-terminal protein amino acid modification|
|regulation of chromatin silencing|
|histone H4 acetylation|
|histone acetylation|
|internal peptidyl-lysine acetylation|
|peptidyl-lysine acetylation|
|internal protein amino acid acetylation|
|regulation of gene silencing|
|protein acetylation|
|protein acylation|
|regulation of chromatin organization|
|protein maturation|
|peptidyl-lysine modification|
|regulation of chromosome organization|
|histone modification|
|covalent chromatin modification|
|chromatin organization|
|peptidyl-amino acid modification|
|chromosome organization|
|lipid metabolic process|
|regulation of organelle organization|
|gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp182|IU1-47 25μM R04 exp182]]|1.7|
|[[:results:exp499|LY2090314 0.003μM R08 exp499]]|1.74|
|[[:results:exp198|Etoposide 0.1μM R05 exp198]]|1.93|
|[[:results:exp288|HMS-I2 10μM R06 exp288]]|1.93|
|[[:results:exp220|BAY-598 4μM R05 exp220]]|2.06|
|[[:results:exp360|Genistein 15μM R07 exp360]]|2.22|
|[[:results:exp306|Rapamycin 2μM R07 exp306]]|2.32|
|[[:results:exp281|Disulfiram 4.3μM R06 exp281]]|2.34|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 4869
* **Expression level (log2 read counts)**: 6.04
{{:chemogenomics:nalm6 dist.png?nolink |}}